BESIVANCE: payments to doctors
Payments that named BESIVANCE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $237K
- Providers
- 3,133
- Transactions
- 8,416
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,133 providers the average total is $76, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $222,892 | 93.9% |
| Bausch Health US, LLC | $9,140 | 3.9% |
| Bausch & Lomb Americas Inc. | $5,267 | 2.2% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $83 | 0.0% |